<DOC>
	<DOCNO>NCT01077479</DOCNO>
	<brief_summary>The main purpose study assess efficacy metformin abrogate androgen deprivation therapy ( ADT ) induce insulin resistance measure homeostasis model assessment ( HOMAIR ) men non-metastatic prostate cancer .</brief_summary>
	<brief_title>Metformin Preventing Androgen Deprivation Therapy Induced Insulin Resistance Metabolic Syndrome</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Hypercholesterolemia</mesh_term>
	<mesh_term>Metabolic Syndrome X</mesh_term>
	<mesh_term>Insulin Resistance</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Metformin</mesh_term>
	<mesh_term>Androgens</mesh_term>
	<criteria>≥ 18 year age ECOG ≤ 1 Histologically confirm prostate cancer early locally advanced stage , metastatic prostate cancer bone involvement ( ≤ 5 site bone metastasis ) Plan receive ≥ 6 month continuous androgen deprivation therapy GnRH agonist Patients receive antiandrogens GnRH agonist exclude study . But form , dose duration antiandrogen treatment record . Adequate renal function ( Creatinine ≤ 177mMol/L GFR &gt; 30 mls/min ) Adequate hepatic function ( Bilirubin must ≤ 1.5 x upper limit normal range , ALT ALP must ≤ 2.5 x upper limit normal ) Visceral involvement &gt; 5 site bone metastases History confirm diabetes mellitus ( patient impair fast glucose impair glucose intolerance exclude ) 12 Treatment medication may alter glucose insulin level within 3 month ( include insulin , oral hypoglycemic agent , systemic corticosteroid dosage , atypical antipsychotic drug dose ) Malignant disease prostate cancer time enrolment Bilateral orchiectomy Previous androgen deprivation therapy GnRH agonist antiandrogen within last 12 month ( patient GnRH agonist 12 month ago allow testosterone level normal range time recruitment ) Chemotherapy within 6 month History lactic acidosis Cardiac respiratory insufficiency , severe infection likely increase risk lactic acidosis Medical psychiatric condition compromise patient 's ability give inform consent</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2014</verification_date>
	<keyword>body fat mass gain</keyword>
	<keyword>Insulin resistance</keyword>
</DOC>